First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
about
An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction.Gonadotrophins: The future.A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity.The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist.Efficacy of corifollitropin alfa followed by recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist protocol for Korean women undergoing assisted reproduction.Historical perspectives in gonadotrophin therapy.Emerging drugs in assisted reproduction.Efficacy of native and hyperglycosylated follicle-stimulating hormone analogs for promoting fertility in female mice.Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patientsAdvances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.Evaluation of results obtained with corifollitropin alfa after poor ovarian response in previous cycle using recombinant follicular stimulating hormone in the long-term protocol.Corifollitropin alfa: a novel long-acting recombinant follicle-stimulating hormone agonist for controlled ovarian stimulation.Corifollitropin alfa for female infertility.Designing a Long Acting Erythropoietin by Fusing Three Carboxyl-Terminal Peptides of Human Chorionic Gonadotropin β Subunit to the N-Terminal and C-Terminal Coding Sequence.Half-life extended biotherapeutics.A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis.A successful conception by a shift from human menopausal gonadotropin therapy to therapy with recombinant human follicular-stimulating hormone for the treatment of male hypogonadotropic hypogonadism.
P2860
Q30313362-B81273EE-EC97-42FD-A178-945C34DD42DDQ33807434-4F614058-009F-4147-BF58-28B80FA6A226Q34975528-A9BBEB35-9952-45E5-9A58-0204878A77CBQ34997672-F98573D9-3D53-4EF3-B826-E910E30AE2F0Q35108282-912AF6A5-FB48-4777-A378-436D1D1155A0Q35186161-57FDE332-EE25-492E-8991-2796B79D1457Q35833291-1E1835AC-2094-493A-9D1B-B7DC5977EA37Q35896964-13402674-910E-4FA5-9A47-B2B1F2D3E640Q36150659-CF22516C-0B89-4B94-A25F-A9AE5CEB6324Q37357158-57DFDA1A-986A-4392-BE34-3EEA0AA736C8Q37358128-5885B246-8917-49DB-B010-C6962A250297Q37381361-45E4EF55-3844-470C-AF1B-5DBC48B45B24Q37604827-2CB10894-6B6D-4AE7-AD2A-5AB41F892768Q37795798-FD363A40-F071-4920-8502-D33C1784195BQ37962998-524184A7-F358-451E-87DF-B1104C5854BDQ38253856-F6D20B5C-4E54-468A-AFAA-38887E4752C5Q38770067-F33932E1-FCD0-4CFF-9885-31C498B8CA92Q48742001-1D0C221A-A99F-4D75-ABD1-B104BC2F4487Q51818158-9FD90132-8CE7-4FC9-ABCB-41314BBE1065Q55083965-9B67FBBD-5671-44D7-A485-DA6574B3E352
P2860
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
@en
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
@nl
type
label
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
@en
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
@nl
prefLabel
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
@en
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
@nl
P2093
P356
P1433
P1476
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
@en
P2093
D J Handelsman
E Nieschlag
F Jockenhövel
FSH-CTP study group
G Voortman
J Itskovitz-Eldor
J J de Bie
J Rabinovici
P M Bouloux
P304
P356
10.1093/HUMREP/16.8.1592
P407
P577
2001-08-01T00:00:00Z